Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 555846

UPA and PAI-1 can be novel predictive parameter for the prognosis of differentiated thyroid carcinoma patients


Horvatić Herceg, Gordana; Herceg, Davorin; Bence-Žigman, Zdenka; Tomić-Brzac, Hrvojka; Kusačić-Kuna, Sanja; Kralik, Marko; Kulić, Ana
uPA and PAI-1 can be novel predictive parameter for the prognosis of differentiated thyroid carcinoma patients // European Journal of nuclear medicine and molecular imaging
Birmingham, Engleska, 2011. str. s347-s347 (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 555846 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
UPA and PAI-1 can be novel predictive parameter for the prognosis of differentiated thyroid carcinoma patients

Autori
Horvatić Herceg, Gordana ; Herceg, Davorin ; Bence-Žigman, Zdenka ; Tomić-Brzac, Hrvojka ; Kusačić-Kuna, Sanja ; Kralik, Marko ; Kulić, Ana

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
European Journal of nuclear medicine and molecular imaging / - , 2011, S347-s347

Skup
Anual Congress of the EANM

Mjesto i datum
Birmingham, Engleska, 15-19.10.2011

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
uPA and PAI-1; differentiated thyroid carcinoma; prognosis

Sažetak
Higher levels of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) are linked to the poor prognosis in a variety of malignances. Aim of the present study was to investigate the expression and clinical relevance of uPA and PAI-1 in differentiated thyroid cancer. Patients and methods: Analysis prospectively included 128 patients with thyroid tumors, among them 105 patients with differentiated thyroid carcinoma, 2 patients with anaplastic carcinoma and 21 patient with thyroid adenoma, who underwent surgery between 2002. and 2008. uPA and PAI-1 in paired cytosol samples of thyroid tumor and normal tissue were determined using enzyme-linked immunosorbent assay and correlated to the known prognostic features. Results: Both uPA and PAI-1 concentrations were significantly higher in differentiated thyroid tumors (uPA = 0.509±0.767 and PAI-1 = 6.337±6.415 ng/mg protein) than in normal tissue (uPA = 0.237±0.051, P<0.001 and PAI-1 =2.368 ±0.418 ng/mg protein, P<0, 001) with positive correlation of the two proteins in the tumors (Pearson r=0.817, Spearman ρ=0.475, P<0.001). Both proteins’ concentrations were significantly different among various histological grades, showing higher values in higher tumor grades. uPA and PAI-1 were significantly higher if extrathyroidal invasion (uPA P=0.015, PAI-1 P <0.001) or distant metastases (PAI-1 P<0.001) had been present, and in tumors whose size exceeded 1 cm in diameter (uPA P=0.002 and PAI-1 P=0.001). Only uPA, but not PAI-1 was significantly higher in multicentric vs. solitary tumors. The differences of uPA and PAI-1 did not reach the significant level when patients with differentiated tumors below and above 40 years of age had been compared and in lymph node positive tumors compared to lymph node negative tumors. Survival analysis revealed the significant impact of both uPA and PAI-1 on the Progression-Free Survival (PFS) (82.22 vs. 49.478 months for patients with low and high uPA, respectively, P < 0.001 ; 8.068 vs. 44.964 months for patients with low and high PAI-1, respectively, P<0.001). Univariate analysis showed that sex, tumor size, gradus, extrathyroid invasion, local lymph nodes involvement, distant metastases, uPA and PAI-1 were significant predictors of PFS. Multivariate analysis confirmed that only distant metastases (P = 0.037), tumor tissue uPA (P= 0.009), and PAI-1 (P= 0, 06) were strong independent predictors of PFS in patients with differentiated thyroid carcinoma. Conclusion: The correlation of high uPA and PAI-1 with the known prognostic factors of poorer outcome and with lower PFS rate in patients with differentiated thyroid cancers proved that these proteins could be an additional prognostic parameter.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
214-1080058-0488 - PROGNOSTIČKI POKAZATELJI BIOLOŠKOG PONAŠANJA KARCINOMA ŠTITNJAČE (Bence-Žigman, Zdenka, MZOS ) ( POIROT)

Ustanove:
Kineziološki fakultet, Zagreb


Citiraj ovu publikaciju

Horvatić Herceg, Gordana; Herceg, Davorin; Bence-Žigman, Zdenka; Tomić-Brzac, Hrvojka; Kusačić-Kuna, Sanja; Kralik, Marko; Kulić, Ana
uPA and PAI-1 can be novel predictive parameter for the prognosis of differentiated thyroid carcinoma patients // European Journal of nuclear medicine and molecular imaging
Birmingham, Engleska, 2011. str. s347-s347 (poster, međunarodna recenzija, sažetak, znanstveni)
Horvatić Herceg, G., Herceg, D., Bence-Žigman, Z., Tomić-Brzac, H., Kusačić-Kuna, S., Kralik, M. & Kulić, A. (2011) uPA and PAI-1 can be novel predictive parameter for the prognosis of differentiated thyroid carcinoma patients. U: European Journal of nuclear medicine and molecular imaging.
@article{article, year = {2011}, pages = {s347-s347}, keywords = {uPA and PAI-1, differentiated thyroid carcinoma, prognosis}, title = {uPA and PAI-1 can be novel predictive parameter for the prognosis of differentiated thyroid carcinoma patients}, keyword = {uPA and PAI-1, differentiated thyroid carcinoma, prognosis}, publisherplace = {Birmingham, Engleska} }
@article{article, year = {2011}, pages = {s347-s347}, keywords = {uPA and PAI-1, differentiated thyroid carcinoma, prognosis}, title = {uPA and PAI-1 can be novel predictive parameter for the prognosis of differentiated thyroid carcinoma patients}, keyword = {uPA and PAI-1, differentiated thyroid carcinoma, prognosis}, publisherplace = {Birmingham, Engleska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font